Cart
sales@molnova.com
NHS-PEG1-SS-PEG1-NHS
CAS No. 1688598-83-5
NHS-PEG1-SS-PEG1-NHS( —— )
Catalog No. M35095 CAS No. 1688598-83-5
NHS-PEG1-SS-PEG1-NHS is a reversible linker used for interacting biomolecules with active small molecules and is effective for linking protein liposomes or nanoparticles (NHS-PEG1-SS-PEG1-NHS).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 38 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 38 | In Stock |
|
| 25MG | 49 | In Stock |
|
| 50MG | 60 | In Stock |
|
| 100MG | 83 | In Stock |
|
| 200MG | 128 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNHS-PEG1-SS-PEG1-NHS
-
NoteResearch use only, not for human use.
-
Brief DescriptionNHS-PEG1-SS-PEG1-NHS is a reversible linker used for interacting biomolecules with active small molecules and is effective for linking protein liposomes or nanoparticles (NHS-PEG1-SS-PEG1-NHS).
-
DescriptionNHS-PEG1-SS-PEG1-NHS is a reversible linker for biomacromolecule link with active small molecule. NHS-PEG1-SS-PEG1-NHS can be used in proteins liposomes or nanoparticles.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1688598-83-5
-
Formula Weight436.41
-
Molecular FormulaC14H16N2O10S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (229.14 mM; Ultrasonic )
-
SMILESO=C(OCCSSCCOC(=O)ON1C(=O)CCC1=O)ON1C(=O)CCC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Thomas Andresen. Reversible linkers and use thereof. WO2019050977A1.
molnova catalog
related products
-
Pre-S1 (12-32)
Pre-S1 (12-32)
-
N6F11
N6F11 is a novel, selective and potent inducer of ferroptosis with anticancer and antitumour activity that promotes GPX4 degradation by binding to TRIM25 in cancer cells.
-
Saikosaponin C
Saikosaponin C efficiently inhibited LPS-induced apoptotic cell death via inhibition of caspase-3 activation and caspase-3-mediated-FAK degradation.
